| LecTec
Set To Launch Headache/Fever Patches
TheraPatch®
Fever and TheraPatch® Headache
Ready For Retail Distribution
November 11,
1999-Minnetonka, MN-LecTec Corporation (Nasdaq National
Market: LECT) today announced the launch of two new
TheraPatch products. In December 1999, the Company plans to
start shipping to retailers its new TheraPatch Headache Cool
Gel patch, which provides instant cooling comfort from
tension, sinus and migraine headaches, and TheraPatch Fever
Cool Gel patch "For Kids," which was developed to provide
cooling comfort for children.
TheraPatch Headache
and TheraPatch Fever are positioned to compliment
pain-relieving and fever medications in the $2.8 billion
analgesic market. TheraPatch Fever and TheraPatch Headache
products are drug free, latex free and safe to use with
medications. "We have already received orders and
commitments from many major retail buyers who plan to stock
and sell our two newest innovative patch products,"
commented Timothy R. J. Quinn, General Manager of LecTec's
Consumer Products Division. "Results from our consumer focus
groups indicate a strong acceptance of our instant cooling
comfort therapy patches. When used by themselves or in
conjunction with pain-relieving or fever medications, our
new TheraPatch Headache and Fever "For Kids" patches are
excellent products."
With these two
products, a total of nine TheraPatch products will be
available nationwide at national food, drug and mass
retailers. TheraPatch products already available include:
TheraPatch Cool and TheraPatch Warm, which provide temporary
relief from minor aches and pains; TheraPatch Anti-Itch "For
Kids" and TheraPatch Anti-Itch "Outdoors," which provide
temporary relief from the itching and pain associated with
insect bites, minor skin irritations, and rashes due to
poison ivy/oak/sumac; and TheraPatch Vapor Chest, TheraPatch
Vapor Nose & Chin and TheraPatch Vapor Cherry Patch "For
Kids," which provide temporary relief from coughs due to
colds.
"The introduction of
TheraPatch Headache and TheraPatch Fever once again
demonstrate LecTec's innovation, speed to market
capabilities and the many applications of our patented
hydrogel/patch technology," said Rodney A. Young, LecTec's
Chairman, CEO and President.
LecTec is a health
care and consumer products company that develops,
manufactures and markets products based on its advanced skin
interface technologies. Primary products include
over-the-counter patch products, diagnostic electrodes and
conductive hydrogels for electrocardiography and related
applications, and a full line of medical tapes.
This press release
contains forward-looking statements that may include
statements regarding intent, belief or current expectations
of the company and its management. These forward-looking
statements are not guarantees of future performance and
involve a number of risks and uncertainties that may cause
the Company's actual results to differ materially from the
results discussed in these statements. Factors that might
cause such differences include, but are not limited to,
buying patterns of major customers, market acceptance of
LecTec's products, competitive products, impact of
interruptions to production, availability of capital to
finance growth, regulatory risks and other risks and
uncertainties detailed from time to time in the Company's
filings with the Securities and Exchange Commission.
Contact: Rodney A.
Young, CEO or Timothy R. J. Quinn, General Manager Consumer
Products
|